Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Brendan Carey

Showing results (1-10 of 22) with videos related to

Pageof 3
Sort By:
Cancer Imaging : the Official Publication of the International Cancer Imaging Society|March 7, 2007
The current role of imaging for prostate brachytherapyBrendan Carey, Sarah Swift
Current Opinion in Urology|March 19, 2014
Focal radiotherapy as focal therapy of prostate cancerGyörgy Kovács, Jean-Marc Cosset, Brendan Carey
Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology|September 29, 2015
Comparison of focal boost high dose rate prostate brachytherapy optimisation methodsJosh Mason, Peter Bownes, Brendan Carey, et al.
International Journal of Radiation Oncology, Biology, Physics|May 18, 2004
The use of linked seeds eliminates lung embolization following permanent seed implantation for prostate cancerBashar Al-Qaisieh, Brendan Carey, Dan Ash, et al.
European Urology|August 31, 2014
EAU standardised medical terminology for urologic imaging: a taxonomic approachTillmann Loch, Brendan Carey, Jochen Walz, et al.
Journal of Contemporary Brachytherapy|January 22, 2019
Importance of dynamic contrast enhanced magnetic resonance imaging for targeting biopsy and salvage treatments after prostate cancer recurrenceJosh Mason, Ese Adiotomre, Peter Bownes, et al.
Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology|May 14, 2005
The impact of hormone therapy on post-implant dosimetry and outcome following Iodine-125 implant monotherapy for localised prostate cancerDan Ash, Bashar Al-Qaisieh, David Bottomley, et al.
BJU International|December 22, 2004
Prostate-specific antigen relapse-free survival in patients with localized prostate cancer treated by brachytherapyJoji Joseph, Bashar Al-Qaisieh, Daniel Ash, et al.
Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology|May 17, 2006
The correlation between D90 and outcome for I-125 seed implant monotherapy for localised prostate cancerDan Ash, Bashar Al-Qaisieh, David Bottomley, et al.
Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology|July 3, 2007
A prospective analysis of long-term quality of life after permanent I-125 brachytherapy for localised prostate cancerDan Ash, David Bottomley, Bashar Al-Qaisieh, et al.
Pageof 3

Showing results (1-10 of 22) with videos related to

Sort By:
Pageof 3
Cancer Imaging : the Official Publication of the International Cancer Imaging Society|March 7, 2007
The current role of imaging for prostate brachytherapyBrendan Carey, Sarah Swift
Current Opinion in Urology|March 19, 2014
Focal radiotherapy as focal therapy of prostate cancerGyörgy Kovács, Jean-Marc Cosset, Brendan Carey
Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology|September 29, 2015
Comparison of focal boost high dose rate prostate brachytherapy optimisation methodsJosh Mason, Peter Bownes, Brendan Carey, et al.
International Journal of Radiation Oncology, Biology, Physics|May 18, 2004
The use of linked seeds eliminates lung embolization following permanent seed implantation for prostate cancerBashar Al-Qaisieh, Brendan Carey, Dan Ash, et al.
European Urology|August 31, 2014
EAU standardised medical terminology for urologic imaging: a taxonomic approachTillmann Loch, Brendan Carey, Jochen Walz, et al.
Journal of Contemporary Brachytherapy|January 22, 2019
Importance of dynamic contrast enhanced magnetic resonance imaging for targeting biopsy and salvage treatments after prostate cancer recurrenceJosh Mason, Ese Adiotomre, Peter Bownes, et al.
Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology|May 14, 2005
The impact of hormone therapy on post-implant dosimetry and outcome following Iodine-125 implant monotherapy for localised prostate cancerDan Ash, Bashar Al-Qaisieh, David Bottomley, et al.
BJU International|December 22, 2004
Prostate-specific antigen relapse-free survival in patients with localized prostate cancer treated by brachytherapyJoji Joseph, Bashar Al-Qaisieh, Daniel Ash, et al.
Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology|May 17, 2006
The correlation between D90 and outcome for I-125 seed implant monotherapy for localised prostate cancerDan Ash, Bashar Al-Qaisieh, David Bottomley, et al.
Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology|July 3, 2007
A prospective analysis of long-term quality of life after permanent I-125 brachytherapy for localised prostate cancerDan Ash, David Bottomley, Bashar Al-Qaisieh, et al.
Pageof 3